Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VisMederi does not have its own clinical pipeline. It provides validated analytical testing services—especially serological/virological assays—for global pharmaceutical companies developing vaccines and therapeutics. The company has particular expertise in immunogenicity assessment for influenza vaccines and has expanded into bacterial vaccines and COVID‑19 diagnostics. Its work underpins regulatory submissions worldwide by ensuring robust data quality in late-stage clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VisMederi.